Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Human Umbilical Cord-Derived Mesenchymal Stem Cell Secretome Modulates Ovarian TNF-α, Oxidative Stress, and Serum Estradiol in Letrozole-Induced PCOS Rats

The Indonesian Biomedical Journal · Vol. 18 No. 5 (2026) · hlm. 488–497

DOI
10.18585/inabj.v18i5.4283
ISSN
2085-3297, 2355-9179
Terbit
2026-11-14
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism, anovulation, chronic inflammation, and oxidative stress. Current treatments mainly relieve symptoms without addressing ovarian damage. Human umbilical cord–derived mesenchymal stem cell (hUC-MSC) secretome is a cell-free product with anti-inflammatory, antioxidant, and regenerative effects that avoids cell-related risks, but its role in PCOS remains unclear. This study was conducted to evaluate its effects on ovarian tumor necrosis factor (TNF)-α, oxidative stress, and serum estradiol in letrozole-induced PCOS rats.METHODS: Thirty female Wistar rats were assigned to a normal group, untreated PCOS-induced group, and PCOS-induced groups treated with either 200, 300, or 400 µL hUC-MSC secretome. PCOS was induced with letrozole for 21 days, and confirmed by vaginal cytology on day-22. Ovarian TNF-α expression, serum estradiol, ovarian malondialdehyde (MDA), and ovarian superoxide dismutase (SOD) activity were measured using reverse transcription quantitative polymerase chain reaction (RT-qPCR), enzyme-linked immunosorbent assay (ELISA), the thiobarbituric acid reactive substances (TBARS) assay, and the water-soluble tetrazolium salt (WST) assay, respectively.RESULTS: Letrozole successfully induced PCOS characteristics, which was marked by persistent diestrus and ovarian histological alterations in PCOS-induced groups. Compared with the untreated PCOS group, group receiving 200 µL hUC-MSC secretome showed lower ovarian TNF-α expression and MDA levels, as well as higher SOD activity and serum estradiol concentrations, approaching normal control values, although these differences were not statistically significant. Compared with the other hUC-MSC concentrations, the 200 µL dose showed the most consistent trend across inflammatory, oxidative stress, and hormonal parameters.CONCLUSION: Administration of hUC-MSC secretome, especially 200 µL dose, showed a trend toward reduced ovarian inflammation and oxidative stress in PCOS rats. These findings suggest that hUC-MSC secretome may have potential as a complementary treatment for PCOS.KEYWORDS: polycystic ovary syndrome, hUC-MSC secretome, TNF-α, oxidative stress, estradiol

Kata kunci

Jaringan kolaborasi para penulis

12 penulis · 48 tautan kepenulisan bersama

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Gadjah Mada
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Hanan Asharafi NoviandariAfiliasi tidak diketahui1
Yohanes Widodo WirohadidjojoUniversitas Gadjah Mada1
Arief BudiyantoUniversitas Gadjah Mada1
Farisa AnggreanaUniversitas Gadjah Mada1
Intan ArviantyUniversitas Gadjah Mada1
Miya KhalidahUniversitas Gadjah Mada1
Netty KristinaAfiliasi tidak diketahui1
Nabila Nur FadhilahAfiliasi tidak diketahui1
Pinastya Purwakaning KusumastutiAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Human Umbilical Cord-Derived Mesenchymal Stem Cell Secretome Modulates Ovarian TNF-α, Oxidative Stress, and Serum Estradiol in Letrozole-Induced PCOS Rats</dc:title><dc:creator>Tamara Ayu Widyasuri</dc:creator><dc:creator>Ratna Dewi Puspita</dc:creator><dc:creator>Rul Afiyah Syarif</dc:creator><dc:subject>polycystic ovary syndrome</dc:subject><dc:subject>cell-free therapy</dc:subject><dc:subject>letrozole-induced PCOS</dc:subject><dc:subject>TNF-α</dc:subject><dc:subject>oxidative stress</dc:subject><dc:subject>serum estradiol</dc:subject><dc:subject>ovarian inflammation</dc:subject><dc:subject>malondialdehyde</dc:subject><dc:subject>superoxide dismutase</dc:subject><dc:subject>ovarian function</dc:subject><dc:subject>antioxidant and anti-inflammatory effects</dc:subject><dc:subject>dose-dependent effects</dc:subject><dc:description xml:lang="en">BACKGROUND: Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism, anovulation, chronic inflammation, and oxidative stress. Current treatments mainly relieve symptoms without addressing ovarian damage. Human umbilical cord–derived mesenchymal stem cell (hUC-MSC) secretome is a cell-free product with anti-inflammatory, antioxidant, and regenerative effects that avoids cell-related risks, but its role in PCOS remains unclear. This study was conducted to evaluate its effects on ovarian tumor necrosis factor (TNF)-α, oxidative stress, and serum estradiol in letrozole-induced PCOS rats.METHODS: Thirty female Wistar rats were assigned to a normal group, untreated PCOS-induced group, and PCOS-induced groups treated with either 200, 300, or 400 µL hUC-MSC secretome. PCOS was induced with letrozole for 21 days, and confirmed by vaginal cytology on day-22. Ovarian TNF-α expression, serum estradiol, ovarian malondialdehyde (MDA), and ovarian superoxide dismutase (SOD) activity were measured using reverse transcription quantitative polymerase chain reaction (RT-qPCR), enzyme-linked immunosorbent assay (ELISA), the thiobarbituric acid reactive substances (TBARS) assay, and the water-soluble tetrazolium salt (WST) assay, respectively.RESULTS: Letrozole successfully induced PCOS characteristics, which was marked by persistent diestrus and ovarian histological alterations in PCOS-induced groups. Compared with the untreated PCOS group, group receiving 200 µL hUC-MSC secretome showed lower ovarian TNF-α expression and MDA levels, as well as higher SOD activity and serum estradiol concentrations, approaching normal control values, although these differences were not statistically significant. Compared with the other hUC-MSC concentrations, the 200 µL dose showed the most consistent trend across inflammatory, oxidative stress, and hormonal parameters.CONCLUSION: Administration of hUC-MSC secretome, especially 200 µL dose, showed a trend toward reduced ovarian inflammation and oxidative stress in PCOS rats. These findings suggest that hUC-MSC secretome may have potential as a complementary treatment for PCOS.KEYWORDS: polycystic ovary syndrome, hUC-MSC secretome, TNF-α, oxidative stress, estradiol</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2026-11-14</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v18i5.4283</dc:identifier><dc:identifier>10.18585/inabj.v18i5.4283</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 18 No 5 (2026); 488-497</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/4283/879</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>